hVIVO plc Annual Report in full & Notice of AGM

hVIVO plc (Euronext & LON:HVO), (formerly Open Orphan plc) a rapidly growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, has confirmed that the Company’s Annual Report and Accounts for the year ended 31 December 2022 and the Notice of Annual General Meeting (“AGM”) will be posted to shareholders today.

The 2022 Annual Report and Accounts can be found below, the Notice of AGM and accompanying form of proxy are available to download from the Company’s website www.hvivo.com.

The Annual General Meeting will be held at the offices of DAC Beachcroft LLP, 25 Walbrook, London EC4N 8AF, United Kingdom on 23 May 2023 at 11 am.

hVIVO-Annual-Report-2022 Download

Share on:

Written by: Madison Wilson

Find more news, interviews, share price & company profile here for:
hVIVO plc

Latest Company News

Precision-driven recruitment that accelerates clinical trial success

May 22, 2025

Discover how hVIVO's recruitment division sets the gold standard in clinical trials, delivering efficient, tailored participant sourcing for diverse studies.

hVIVO proves it can deliver big on high-volume vaccine trials

May 13, 2025

hVIVO has showcased its excellence in clinical research by successfully executing a large-scale flu vaccine trial, demonstrating agility and operational expertise under tight deadlines.

hVIVO publishes 2024 report and announces Board changes

May 12, 2025

hVIVO plc announces the release of its 2024 Annual Report and upcoming AGM, along with notable board changes, including the departure of key directors.